Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesPneumococcal conjugated vaccine: PHiD-CV
Expert Review of Anti-infective Therapy, 11/10/09
Dinleyici EC et al. – It has been proved that PHiD–CV is immunogenic, safe and well–tolerated in children. This vaccine can be coadministered with routinely used pediatric vaccines. PHiD–CV is also immunogenic for ten serotypes as assessed by post–primary and post–booster dose opsonophagocytic activity responses. Optimal scheduling, safety and immunogenicity data in children with different risk factors for IPD, or whether it will provide herd immunity, are the questions waiting for answers in the postmarketing period.
Related Articles
CDC Survey Shows Gains in Overall Adolescent Vaccination Rates for 2008. But Majority Still Lack Immunizations for Tdap, MCV4
American Family Physician, 10/23/09
Relevance Score: 99%
A survey of adolescent experiences of human papillomavirus vaccination in the Manchester study
British Journal of Cancer, 10/09/09
Relevance Score: 97%
One Dose of H1N1 Vaccine Immunogenic in High Percentage of Youth Ages 10 to 17. Younger Children Likely Will Need Two Doses
American Family Physician, 10/05/09
Relevance Score: 97%
Human Papillomavirus Vaccine Uptake, Predictors of Vaccination, and Self-Reported Barriers to Vaccination
Journal of Women's Health, 10/05/09
Relevance Score: 96%
H1N1 Vaccine Deliveries Begin. Early Doses to Arrive This Week
American Family Physician, 10/07/09
Relevance Score: 95%
Today in Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Recognition, Diagnosis, and Treatment of Histoplasmosis Complicating Tumor Necrosis Factor Blocker Therapy
Clinical Infectious Diseases, 12/07/09
The Impact of The President’s Emergency Plan for AIDS Relief (PEPfAR) beyond HIV and Why It Remains Essential
Clinical Infectious Diseases, 12/07/09
Linezolid in the Treatment of Multidrug-Resistant Tuberculosis
Clinical Infectious Diseases, 12/07/09
Sponsor
Article Search
Sponsor